Taking Your Compound To The Next Level

Blog_header_800x200_v2.jpg... because Targeted Therapy Requires Highly Accurate Models

State-of the-art PDX and CDX Efficacy Studies

With the development of new targeted therapeutics, comes the requirement of using accurate models for preclinical efficacy studies. Our high fidelity PDX models ultimately reduce cost due to higher predictability in clinical outcome.

 What we offer: 

  • World-class breast cancer PDX collection, including 8 rare ER+ and 12 TNBC models
  • World-class Melanoma PDX collection with Braf resistant models
  •  PDX breast cancer cells for your research
  • In vivo efficacy studies
  • Cell line Derived Xenograft (CDX) Models for Growth and Efficacy Studies

 For more information on our PDX Models complete the form to access the downloads